XOMA Royalty Corporation
NASDAQ: XOMAP0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Owen Patrick Hughes
- Employees
- 14
- Headquarters
- Emeryville, United States
- IPO year
- 2020
- Market cap
- $307.7M
- Website
- https://www.xoma.com
Loading XOMAP…
Loading profile data…Frequently asked questions about XOMAP
What does XOMA Royalty Corporation (XOMAP) do?
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stag...
Where does XOMAP trade?
XOMA Royalty Corporation (XOMAP) trades on the NASDAQ.
What sector is XOMAP in?
XOMA Royalty Corporation (XOMAP) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of XOMA Royalty Corporation?
Owen Patrick Hughes is the chief executive officer of XOMA Royalty Corporation (XOMAP).
Where is XOMA Royalty Corporation headquartered?
XOMA Royalty Corporation is headquartered in United States.
Does XOMAP pay a dividend?
Yes — XOMA Royalty Corporation (XOMAP) paid a trailing twelve-month dividend of USD 2.16 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did XOMAP go public?
XOMA Royalty Corporation (XOMAP) completed its initial public offering in 2020.